Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro.

Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro.

1. Vasoactive intestinal polypeptide (VIP) is present in high concentrations in the hypothalamus and appears to be involved in the modulation of growth hormone (GH) secretion. The effects of VIP on hypothalamic somatostatin (SMS) release are, however, controversial. 2. To further elucidate the mecha...

Full description

Bibliographic Details
Main Authors:	Lengyel, A, Grossman, A, Rees, L, Besser, G
Format:	Journal article
Language:	English
Published:	1989

Similar Items

Glucose-induced changes in somatostatin-14 and somatostatin-28 released from rat hypothalamic fragments 'in vitro'.
by: Lengyel, A, et al.
Published: (1984)

Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1984)

Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1985)

Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in-vitro release from hypothalamic explants.
by: Ge, F, et al.
Published: (1989)

EFFECTS OF ACETYLCHOLINE AND NORADRENALINE ON IMMUNOREACTIVE CRF-41 RELEASE FROM INCUBATED RAT HYPOTHALAMIC FRAGMENTS INVITRO
by: Besser, G, et al.
Published: (1988)

The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies.
by: Grossman, A, et al.
Published: (1993)

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
by: Ross, R, et al.
Published: (1987)

Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro.
by: Yasin, SA, et al.
Published: (1993)

The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
by: Delitala, G, et al.
Published: (1983)

Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis.
by: Williams, R
Published: (2002)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
by: Korbonits, M, et al.
Published: (1998)

Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release
by: Ismail, I.S., et al.
Published: (1995)

THE EFFECT OF DEHYDROEPIANDROSTERONE ADMINISTERED IN-VIVO ON WISTAR RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE CONTENT AND RELEASE ASSESSED IN-VITRO
by: Svec, F, et al.
Published: (1993)

New hypothalamic hormone, corticotropin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man.
by: Grossman, A, et al.
Published: (1982)

Combined use of vasopressin and synthetic hypothalamic releasing factors as test of anterior pituitary function.
by: Grossman, A, et al.
Published: (1986)

THE REGULATION OF HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR RELEASE - INVITRO STUDIES
by: Grossman, A, et al.
Published: (1993)

Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.
by: Grossman, A, et al.
Published: (1984)

Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
by: Christian, H, et al.
Published: (2007)

Interleukin-1 beta and interleukin-6 specifically increase the release of prostaglandin E2 from rat hypothalamic explants in vitro.
by: Navarra, P, et al.
Published: (1992)

Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
by: Adriaenssens, A, et al.
Published: (2023)

Novel regulators of the in vitro release of hypothalamic corticotrophin-releasing hormone two decades after its discovery: a review.
by: Costa, A, et al.
Published: (2001)

Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiency.
by: Sopwith, A, et al.
Published: (1986)

Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants.
by: Costa, A, et al.
Published: (1992)

Mechanisms of storage and release of vasoactive molecules in endothelial cells – Endothelin-1
by: Banecki, KMRM
Published: (2024)

Involvement of calmodulin in depolarization-induced release of corticotrophin-releasing hormone-41 from the rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1991)

Growth-hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release.
by: Grossman, A, et al.
Published: (1983)

Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.
by: Tsagarakis, S, et al.
Published: (1990)

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
by: Looij, B, et al.
Published: (1986)

Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect.
by: Honegger, J, et al.
Published: (1991)

Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1988)

CRANIAL IRRADIATION FOR CEREBRAL-TUMORS IN CHILDHOOD - EVIDENCE FOR A HYPOTHALAMIC DEFECT IN GROWTH-HORMONE RELEASE
by: Savage, M, et al.
Published: (1985)

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.
by: Coleman, T, et al.
Published: (2006)

Stimulation of Alpha-Adrenoceptors Facilitates the Release of Growth Hormone-Releasing Hormone from Rat Hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1989)

Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro.
by: Tsagarakis, S, et al.
Published: (1989)

The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
by: Korbonits, M, et al.
Published: (1999)

Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1990)

Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro.
by: Ibanez-Santos, J, et al.
Published: (1990)

Effects of gastric inhibitory polypeptide, somatostatin and epidermal growth factor on lipogenesis in ovine adipose explants
by: Baba, A.S.H., et al.
Published: (2000)

Nitric oxide modulates the release of vasopressin from rat hypothalamic explants.
by: Yasin, S, et al.
Published: (1993)

Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1989)